logo
Select company
Select metric
0%Cost of Revenue Margin
VS
Market
84
Sector
78
Industry
53
History
-
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Cost of Revenue Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - COGS % Historical data
DateCost of RevenueCost of Revenue MarginRevenues
6/30/2025$ 00%$ 1.03M
3/31/2025$ 00%$ 34.17M
12/31/2024$ 00%$ 38.91M
9/30/2024$ 00%$ 47.94M
6/30/2024$ 00%$ 54.1M
3/31/2024$ 00%$ 25.91M
12/31/2023$ 00%$ 26M
9/30/2023$ 00%$ 34.53M
6/30/2023$ 00%$ 48.69M
3/31/2023$ 00%$ 82.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) COGS % stands at 0%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average COGS % has been 0%.
  • The median COGS % for CARTESIAN THERAPEUTICS INC during this period was 0%
  • CARTESIAN THERAPEUTICS INC reached its highest COGS % over the past 5 years at 0%.
  • The lowest COGS % recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 0%

CARTESIAN THERAPEUTICS INC's COGS % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

COGS % Benchmarks
CompanyCOGS %
HUMA : HUMACYTE INC 44.01%NWBO : NORTHWEST BIOTHERAPEUTICS INC 0%MREO : MEREO BIOPHARMA GROUP PLC 26.4%INBX : INHIBRX BIOSCIENCES INC 0%CRDF : CARDIFF ONCOLOGY INC 0%BTAI : BIOXCEL THERAPEUTICS INC 244.59%CATX : PERSPECTIVE THERAPEUTICS INC 0%ADVM : ADVERUM BIOTECHNOLOGIES INC 0%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 0%LSTA : LISATA THERAPEUTICS INC 0%

Definition of Cost of Revenue Margin

[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
COGS / Revenues
(=) COGS %
COGS % for CARTESIAN THERAPEUTICS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 11.3M ]
(=) COGS % [ 0% ]

RNAC - Cost of Revenue Margin, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

COGS % Benchmark Analysis

The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.88% with a standard deviation of 31.58%.
The following table provides additional summary stats:
COGS % in the Market:
filtered constituents3.8K
min-50.26%
max172.25%
average46.88%
median50.52%
std31.58%